Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Type
Date
News Topics
- (-) Critical Materials (1)
- 3-D Printing/Advanced Manufacturing (9)
- Advanced Reactors (7)
- Artificial Intelligence (7)
- Big Data (2)
- Bioenergy (7)
- Biology (6)
- Biomedical (13)
- Biotechnology (1)
- Buildings (1)
- Chemical Sciences (7)
- Clean Water (2)
- Climate Change (1)
- Composites (2)
- Computer Science (14)
- Coronavirus (8)
- Cybersecurity (1)
- Decarbonization (5)
- Education (1)
- Energy Storage (10)
- Environment (10)
- Exascale Computing (1)
- Fossil Energy (2)
- Frontier (2)
- Fusion (22)
- Grid (2)
- High-Performance Computing (4)
- Isotopes (1)
- ITER (6)
- Machine Learning (3)
- Materials (14)
- Materials Science (25)
- Mathematics (1)
- Microscopy (4)
- Nanotechnology (11)
- National Security (2)
- Net Zero (1)
- Neutron Science (101)
- Nuclear Energy (29)
- Partnerships (3)
- Physics (10)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (7)
- Security (3)
- Simulation (3)
- Space Exploration (3)
- Summit (6)
- Sustainable Energy (6)
- Transportation (9)
Media Contacts
ORNL scientists combined two ligands, or metal-binding molecules, to target light and heavy lanthanides simultaneously for exceptionally efficient separation.